Almost every cell in your body runs on fuel made by mitochondria, and how well they work shapes how you feel day to day. This topic covers peptides for energy and the molecules behind it — NAD, which cells use to move energy around, and mitochondrial peptides like MOTS-c and SS-31.

The articles explain the science the way you'd want a friend to: what these compounds are, what studies show, and what's still unproven. All are prescription-only through a licensed provider.

4 articles on this topic

  1. A man performs a controlled dumbbell curl beside a window in a sunlit gym

    MOTS-c Dosage: Why There Is No Standard Dose

    There is no established human MOTS-c dose. Published human research is mostly observational, and the numbers repeated online come largely from mouse experiments rather than clinical dosing trials.

    August 17, 2026 · Priya Raman, Health Writer

  2. A person walking a small dog along a quiet tree-lined sidewalk at sunrise

    SS-31 Peptide: A Patient's Guide to Elamipretide

    SS-31 and elamipretide are two names for the same four-amino-acid peptide, and its branded injectable form received accelerated approval from the FDA on September 19, 2025 for a single ultra-rare genetic disease.

    August 13, 2026 · Julian Reyes, Health Writer

  3. A woman in a cream sweater walking a tree-lined path in morning light

    MOTS-c Peptide Benefits: Rodent Depth, Human Hints

    MOTS-c is a peptide your mitochondria encode themselves — and it is studied for how cells handle fuel. The rodent evidence runs deep; the human evidence is just beginning.

    August 9, 2026 · Nadia Okonjo, Health Writer

  4. A woman stands at a sunlit kitchen counter in the morning, holding a cup of coffee and looking out the window.

    A Patient's Guide to NAD+ Injections

    NAD+ is a coenzyme found in every living cell, yet most human trial data comes from oral precursors like NR and NMN — including a 2025 meta-analysis in adults with mean ages of 61 to 83 that found no significant muscle benefit.

    August 12, 2026 · Nadia Okonjo, Health Writer